Edition:
United Kingdom

Manas Mishra

Abbott hits record high as diabetes device fuels profit beat

17 Jul 2019

Abbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump in sales of its blood sugar monitoring device.

J&J warns of hit from generic drugs in third quarter, shares fall

16 Jul 2019

Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

US STOCKS-Wall Street hits record high on rate cut optimism

12 Jul 2019

* Indexes up: Dow 0.58%, S&P 0.21%, Nasdaq 0.40% (Updates to early afternoon)

Karyopharm Therapeutics prices blood cancer treatment after FDA approval

03 Jul 2019

Karyopharm Therapeutics Inc on Wednesday set a list-price for its blood cancer treatment Xpovio at $22,000 per month, following accelerated approval from the U.S. Food and Drug Administration.

CORRECTED-UPDATE 1-U.S. FDA approves Karyopharm Therapeutics' blood cancer drug

03 Jul 2019

July 3 The U.S. Food and Drug Administration on Wednesday approved Karyopharm Therapeutics Inc's treatment for multiple myeloma, a type of blood cancer.

Mothers' education can matter for diabetic kids

28 Jun 2019

Family background can matter for the health of diabetic children, according to researchers in Denmark who found young patients' blood sugar control was linked with the level of education their mothers had attained.

Sarepta surges after Pfizer gene therapy data raises safety concerns

28 Jun 2019

Shares of Sarepta Therapeutics Inc surged 15% on Friday after some safety concerns were raised in a small, early-stage study of a competing gene therapy for a rare muscle-wasting disorder from Pfizer Inc .

Walgreens beats estimates on prescription drug sales, shares rise

27 Jun 2019

Walgreens Boots Alliance Inc on Thursday posted a better-than-expected quarterly profit as the drugstore chain benefited from a rise in branded drug prices and an increase in the number of prescriptions it fills in the United States.

Elderly in U.S. emergency depts often can't afford medicines

26 Jun 2019

(Reuters Health) - Older adults who come to U.S. emergency rooms often have trouble affording medications, a study shows.

Chewy shares surge 63% in debut as investors bank on booming pet market

14 Jun 2019

Shares of Chewy Inc soared 63% in their public debut, giving the online pet products retailer a market value of $14.35 billion, more than four times the price PetSmart paid for it in 2017. | Video

World News